In this section
This pain management guideline was written by the staff of the Children's Pain Management Service for the Royal Children's Hospital, Melbourne.This guideline may NOT be suitable for use in other institutions
Special patient groups for regional local anaesthetic infusions that may require modified dosing and duration include:
Neonates (<44 weeks corrected PMA)
Infants less than 8 months of age
Children with significantly impaired liver synthetic-metabolic function
These patients may have a higher risk of local anaesthetic toxicity. They have immature liver production of the carrier protein [alpha1 acid glycoprotein: AAG] and may have slower metabolism of local anaesthetics. The unbound fraction causes toxicity. Infants have higher unbound plasma concentrations at 20% for ropivacaine and bupivacaine.
At 8 months of age, infants achieve adult liver handling of local anaesthetics and adult plasma concentrations of AAG at 12 months when the unbound concentration is the same as in adults at 5%. RCH Department of Anaesthesia and Pain Management recommends a conservative dosing schedule in these special groups that may be adjusted according to the patient's comorbidities. For regional (epidural, caudal) infusion:
For wound catheter infusions:
Note Low concentration eg. 0.1% ropivacaine may be ordered to enable greater spread of the block. The anaesthetist writing the order for the infusion should specify the planned duration of the infusion in these special patient groups. The planned time of cessation may be extended upon CPMS review if deemed beneficial for the patient (and the initial infusion dosing has been low).
A range of catheters may be used.
The kits used at RCH
The effectiveness of the analgesia should be recorded in the Nursing Progress notes.
Call CPMS URGENTLY if any of the following occur:
An accredited Registered Nurse can remove the regional anaesthetic catheter after instruction by CPMS or an anaesthetist.
Guideline review date:First version 2006, Updated July 2023